...
机译:大麻素受体1型的正变构调制抑制了病理疼痛而不产生耐受性或依赖性
Program in Neuroscience Indiana University;
Psychological and Brain Sciences Indiana University;
Department of Pharmaceutical Sciences Center for Drug Discovery Bouvé College of Health Sciences;
The Institute of Medical Sciences University of Aberdeen;
Program in Neuroscience Indiana University;
Department of Pharmaceutical Sciences Center for Drug Discovery Bouvé College of Health Sciences;
Program in Neuroscience Indiana University;
Allosteric modulator; Endocannabinoid; Neuropathic pain; Physical dependence; Reward; Withdrawal;
机译:大麻素受体1型的正变构调制抑制了病理疼痛而不产生耐受性或依赖性
机译:缓慢信号传导G蛋白质 - 偏置CB2大麻素受体激动剂Ly2828360抑制了持续疗效和衰减吗啡耐受和依赖性的神经性疼痛
机译:1型大麻素受体的积极变构调制减少了R6 / 2小鼠模型中亨廷顿病的迹象和症状
机译:μ-ApiOID受体和大麻素受体1型在T淋巴细胞中的表达和功能
机译:CB1R大麻素受体在神经性疼痛过程中变构地调节δ阿片受体的活性。
机译:CB1的正构构调节可抑制病理性疼痛而不产生耐受性或依赖性
机译:大麻素受体1型的正变构调制抑制了病理疼痛而不产生耐受性或依赖性